Heard on the Street: Pfizer’s latest multibillion-dollar deal shows it isn’t backing down from the obesity fight. The stock offers a cheap ticket into the hottest corner of pharma.

Pfizer's recent agreement to acquire Metsera for up to $7.3 billion marks a significant return to the obesity drug market, especially after the company previously abandoned an experimental weight-loss pill. This move is crucial as it highlights Pfizer's commitment to addressing the growing obesity epidemic and capitalizing on the increasing demand for effective weight-loss solutions.

Roche is gearing up to launch a late-stage trial for its experimental obesity drug in 2026, aiming to make a significant impact in the weight-loss market before 2030. This move is crucial as it positions Roche to potentially become one of the top three competitors in the field, reflecting the growing demand for effective obesity treatments and the company's commitment to addressing this pressing health issue.

Jayson Tatum, the NBA superstar, recently shared his thoughts in an interview with TODAY after suffering a season-ending Achilles injury. He expressed feelings of betrayal by the sport he loves but remains optimistic about his recovery and plans to return to the court. Tatum also highlighted the immense support he has received from his family during this challenging time. His journey is significant not only for his fans but also for the NBA community, as it showcases resilience and the importance of support in overcoming adversity.

Kenvue is preparing for a surge of lawsuits regarding its widely used pain reliever Tylenol, following a warning from the Trump administration that its active ingredient may be linked to autism when used during pregnancy. This situation is significant as it raises concerns about the safety of a common medication, potentially impacting public perception and sales.

Donald Trump has expressed strong feelings about autism, making it a personal issue for him. His advocacy for autism awareness and support highlights the importance of addressing this condition in healthcare and policy discussions. By sharing his views, Trump aims to bring more attention to the challenges faced by individuals with autism and their families, which is crucial for fostering understanding and improving resources.

Health-tech companies are making strides in cancer prevention by developing AI models that can identify patients at risk of breast cancer. This innovation is crucial as it allows for earlier screenings and preventive care, potentially saving lives and improving health outcomes. With AI's ability to analyze vast amounts of data, the hope is to provide personalized care that can significantly reduce the incidence of cancer.

As the seasons change, board-certified dermatologist Dr. Angela Lamb offers valuable tips on how to adjust your skin care routine for fall. She emphasizes the importance of avoiding harsh ingredients and maintaining sunscreen use, which is crucial even in cooler weather. This advice is particularly relevant as many people experience changes in their skin during the transition to fall, making it essential to adapt our routines for healthier skin.

Recent studies in France have raised serious concerns about the impact of pesticides on the environment and public health. With alarming findings about contamination in air, water, and land, these reports highlight the urgent need for action to address agricultural practices that may be harming communities. This issue matters because it not only affects the safety of food and drinking water but also poses risks to the health of residents living near agricultural areas.